staurosporine has been researched along with birb 796 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Atteridge, CE; Azimioara, MD; Benedetti, MG; Biggs, WH; Carter, TA; Ciceri, P; Edeen, PT; Fabian, MA; Floyd, M; Ford, JM; Galvin, M; Gerlach, JL; Grotzfeld, RM; Herrgard, S; Insko, DE; Insko, MA; Lai, AG; Lélias, JM; Lockhart, DJ; Mehta, SA; Milanov, ZV; Patel, HK; Treiber, DK; Velasco, AM; Wodicka, LM; Zarrinkar, PP | 1 |
| Atteridge, CE; Campbell, BT; Chan, KW; Ciceri, P; Davis, MI; Edeen, PT; Faraoni, R; Floyd, M; Gallant, P; Herrgard, S; Hunt, JP; Karaman, MW; Lockhart, DJ; Milanov, ZV; Morrison, MJ; Pallares, G; Patel, HK; Pritchard, S; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
| Getlik, M; Grütter, C; Klüter, S; Naqvi, T; Pawar, V; Rabiller, M; Rauh, D; Simard, JR | 1 |
| Russu, WA; Shallal, HM | 1 |
| Ciceri, P; Davis, MI; Herrgard, S; Hocker, M; Hunt, JP; Pallares, G; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
| Cunliffe, V; Frearson, J; Fujino, A; Gordon, R; Harris, CJ; Imai, M; Imaizumi, K; Kalloo-Hosein, H; Kambe, M; Kataoka, K; Kobayashi, S; Komatsu, K; Kosugi, T; Le, J; Makino, H; Matsueda, Y; Mitchell, DR; Oue, Y; Patel, G; Sakai, Y; Sherborne, B; Simpson, DJ; Sugiura, S; Suzuki, N; Takenouchi, O; Takimoto-Kamimura, M; Thomas, PS; Unoki, G; Yamakoshi, Y | 1 |
| Bagley, MC; Berger, BT; Chaikuad, A; Dauch, D; Dwyer, JE; Harbig, J; Joerger, AC; Knapp, S; Krämer, A; Kudolo, M; Laufer, S; Röhm, S; Schröder, M; Widdowson, CS | 1 |
7 other study(ies) available for staurosporine and birb 796
| Article | Year |
|---|---|
A small molecule-kinase interaction map for clinical kinase inhibitors.
Topics: Benzamides; Drug Design; Escherichia coli; Escherichia coli Proteins; Imatinib Mesylate; Microchemistry; Pharmaceutical Preparations; Piperazines; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Pyrimidines | 2005 |
A quantitative analysis of kinase inhibitor selectivity.
Topics: Binding Sites; Enzyme Activation; Humans; Phosphotransferases; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Proteome; Quantitative Structure-Activity Relationship | 2008 |
Displacement assay for the detection of stabilizers of inactive kinase conformations.
Topics: Crystallography, X-Ray; Drug Design; Mitogen-Activated Protein Kinase 9; Models, Molecular; p38 Mitogen-Activated Protein Kinases; Protein Conformation; Protein Kinase Inhibitors; Pyrazoles; Structure-Activity Relationship; Urea | 2010 |
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Comprehensive analysis of kinase inhibitor selectivity.
Topics: Catalysis; Drug Design; Enzyme Stability; High-Throughput Screening Assays; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Kinases; Proteomics; Signal Transduction; Substrate Specificity | 2011 |
Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-a]pyrimidine inhibitors using a focused library and structure-based optimization approach.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Crystallography, X-Ray; HSP27 Heat-Shock Proteins; Humans; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Phosphorylation; Protein Conformation; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Shock, Septic; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2012 |
Selective targeting of the αC and DFG-out pocket in p38 MAPK.
Topics: Allosteric Regulation; Allosteric Site; Animals; Cell Line, Tumor; Fluorometry; HEK293 Cells; Humans; Mice; Microsomes, Liver; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; Protein Binding; Protein Kinase Inhibitors | 2020 |